Literature DB >> 33098549

Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges.

Tangchun Wu1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33098549      PMCID： PMC7585350          DOI： 10.1007/s11684-020-0823-4

Source DB:  PubMed          Journal:  Front Med        ISSN： 2095-0217            Impact factor:   9.927


× No keyword cloud information.
  19 in total

1.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.

Authors:  Quan-Xin Long; Xiao-Jun Tang; Qiu-Lin Shi; Qin Li; Hai-Jun Deng; Jun Yuan; Jie-Li Hu; Wei Xu; Yong Zhang; Fa-Jin Lv; Kun Su; Fan Zhang; Jiang Gong; Bo Wu; Xia-Mao Liu; Jin-Jing Li; Jing-Fu Qiu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-06-18       Impact factor: 53.440

2.  An Inactivated Virus Candidate Vaccine to Prevent COVID-19.

Authors:  Mark J Mulligan
Journal:  JAMA       Date:  2020-09-08       Impact factor: 56.272

3.  COVID-19 and the Path to Immunity.

Authors:  David S Stephens; M Juliana McElrath
Journal:  JAMA       Date:  2020-10-06       Impact factor: 56.272

4.  T cells found in coronavirus patients 'bode well' for long-term immunity.

Authors:  Mitch Leslie
Journal:  Science       Date:  2020-05-22       Impact factor: 47.728

5.  Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.

Authors:  F Javier Ibarrondo; Jennifer A Fulcher; David Goodman-Meza; Julie Elliott; Christian Hofmann; Mary A Hausner; Kathie G Ferbas; Nicole H Tobin; Grace M Aldrovandi; Otto O Yang
Journal:  N Engl J Med       Date:  2020-07-21       Impact factor: 91.245

6.  Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients.

Authors:  Xiaoli Wang; Xianghua Guo; Qianqian Xin; Yang Pan; Yaling Hu; Jing Li; Yanhui Chu; Yingmei Feng; Quanyi Wang
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

7.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

Authors:  Kelvin Kai-Wang To; Owen Tak-Yin Tsang; Wai-Shing Leung; Anthony Raymond Tam; Tak-Chiu Wu; David Christopher Lung; Cyril Chik-Yan Yip; Jian-Piao Cai; Jacky Man-Chun Chan; Thomas Shiu-Hong Chik; Daphne Pui-Ling Lau; Chris Yau-Chung Choi; Lin-Lei Chen; Wan-Mui Chan; Kwok-Hung Chan; Jonathan Daniel Ip; Anthony Chin-Ki Ng; Rosana Wing-Shan Poon; Cui-Ting Luo; Vincent Chi-Chung Cheng; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Zhiwei Chen; Honglin Chen; Kwok-Yung Yuen
Journal:  Lancet Infect Dis       Date:  2020-03-23       Impact factor: 25.071

8.  SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.

Authors:  Jun Wu; Boyun Liang; Cunrong Chen; Hua Wang; Yaohui Fang; Shu Shen; Xiaoli Yang; Baoju Wang; Liangkai Chen; Qi Chen; Yang Wu; Jia Liu; Xuecheng Yang; Wei Li; Bin Zhu; Wenqing Zhou; Huan Wang; Sumeng Li; Sihong Lu; Di Liu; Huadong Li; Adalbert Krawczyk; Mengji Lu; Dongliang Yang; Fei Deng; Ulf Dittmer; Mirko Trilling; Xin Zheng
Journal:  Nat Commun       Date:  2021-03-22       Impact factor: 14.919

9.  Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.

Authors:  Yun Tan; Feng Liu; Xiaoguang Xu; Yun Ling; Weijin Huang; Zhaoqin Zhu; Mingquan Guo; Yixiao Lin; Ziyu Fu; Dongguo Liang; Tengfei Zhang; Jian Fan; Miao Xu; Hongzhou Lu; Saijuan Chen
Journal:  Front Med       Date:  2020-10-05       Impact factor: 4.592

10.  Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.

Authors:  Fan Wu; Mei Liu; Aojie Wang; Lu Lu; Qimin Wang; Chenjian Gu; Jun Chen; Yang Wu; Shuai Xia; Yun Ling; Yuling Zhang; Jingna Xun; Rong Zhang; Youhua Xie; Shibo Jiang; Tongyu Zhu; Hongzhou Lu; Yumei Wen; Jinghe Huang
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 44.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.